Navigation Links
Study reveals mechanism of lung-cancer drug resistance
Date:1/19/2012

  • The most common form of lung cancer inevitably develops resistance to the targeted drug gefitinib.
  • This study shows how this resistance develops.
  • The findings suggest a new strategy for treating non-small cell lung cancer.

COLUMBUS, Ohio New research published in Nature Medicine indicates that targeted drugs such as gefitinib might more effectively treat non-small cell lung cancer if they could be combined with agents that block certain microRNAs.

The study was led by investigators with the Ohio State University Comprehensive Cancer Center Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC James). It shows that overexpression of two genes, called MET and EGFR, causes the deregulation of six microRNAs, and that this deregulation leads to gefitinib resistance.

The findings support the development of agents that restore the levels of these microRNAs. It also offers a new strategy for treating non-small cell lung cancer (NSCLC), which is responsible for about 85 percent of the 221,000 lung-cancer cases and 157,000 deaths that occur annually in the United States.

Finally, it suggests that measuring the expression levels of certain microRNAs those controlled by the MET gene might predict which lung-cancer cases are likely to be resistant to gefitinib.

EGFR (which stands for "epidermal growth factor receptor") is frequently overexpressed in non-small cell lung cancer (NSCLC), and this leads to uncontrolled cell proliferation. Gefitinib selectively inhibits EGFR activation and triggers cancer cells to self-destruct by apoptosis. NSCLC cells inevitably develop resistance to the drug, however. This study reveals how this resistance occurs.

"Our findings suggest that gefitinib resistance that is caused by MET overexpression is at least partly due to miRNA deregulation," says principal investigator Dr. Carlo M. Croce, director of Ohio State's Human
'/>"/>

Contact: Darrell E. Ward
Darrell.Ward@osumc.edu
614-293-3737
Ohio State University Medical Center
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Study finds potential key to immune suppression in cancer
2. The Pill Can Help Ease Period Pain, Study Finds
3. University of Maryland study: Headphone-distracted pedestrians face death, serious injury
4. Study reveals origins of esophageal cancer
5. Researchers study how chemicals in drugs and around us impact stem cells
6. UH Case Medical Center publishes study on novel treatment for skin lymphoma
7. Retention study identifies key factors affecting 3 generations of nurses
8. Younger Adults on Multiple Meds at Risk for Falls: Study
9. Vitamin D Wont Help Most COPD Patients: Study
10. Study suggests junk food in schools doesnt cause weight gain among children
11. Childrens Drowning Injuries, Deaths Decline: Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/4/2015)... ... September 04, 2015 , ... San ... available at CitiDent. CEREC is a newer method for creating restorations through innovative ... patients by eliminating the need for multiple appointments, CEREC produces restorations with total ...
(Date:9/4/2015)... , ... September 04, 2015 , ... Many consumers are looking for a quick and ... their solution. , The patent-pending K Med Cups provide a quick and simple way to ... relieve a cold, flu or cough. As a result, they enhance comfort and health. The ...
(Date:9/4/2015)... ... September 04, 2015 , ... The conference program ... Hollywood, Florida October 9-10, 2015 at the Diplomat Resort & Spa has been ... doctors and researchers at the top of their field and will be presenting ...
(Date:9/4/2015)... ... September 04, 2015 , ... Lalonde Gordon ran a 44.64 ... up with victory in the men’s 400 meters final, with an impressive 44.89 seconds ... Championships in San Jose, Costa Rica in August 2015. The 44.64 time is a ...
(Date:9/4/2015)... , ... September 04, 2015 , ... Yisrayl Hawkins, Pastor and Overseer at The House ... are prophetic details involving the Pope’s upcoming trip to the United States. , Yisrayl lays ... his role with the Vatican and society is. Yisrayl also provides the meaning of his ...
Breaking Medicine News(10 mins):Health News:San Francisco Dentist, Dr. Ben Amini, is Now Offering CEREC Technology at CitiDent 2Health News:Redesigned Packaging for Powdered Medicinal Mix Invented by InventHelp® Client (CBA-2637) 2Health News:Integrative Healthcare Symposium Focus On: The Microbiome Conference Program Announced 2Health News:Lalonde Gordon’s Recipe Brings Home the Gold 2Health News:Lalonde Gordon’s Recipe Brings Home the Gold 3Health News:Yisrayl Hawkins Writes Open Letter to Pope Francis In Light of Approaching U.S. Visit 2
... the worldunderstand and prepare for contagious outbreaks, the National ... (MIDAS) adds new research expertise to increase its capacity ... help inform public health officials and policymakers. ... emerged and infected people around the world. In 2003, ...
... ... year old Mitchell Brown ( www.helpmitchell.com ), an athlete, loving young father, and lifetime resident of ... months before the birth of his second child. , ... East Brunswick, NJ (Vocus) September 3, 2009 -- The race is on to find ...
... Positive interaction beats punishment when trying to reach a goal, ... Trying to determine the best way to get people to ... Economics have found that a carrot is better than a ... with each other to solve a group social dilemma, our ...
... , BROOMFIELD, Colo., Sept. 3 Embla(R) and ... acquire Covidien,s Sleep Diagnostic business. This includes the sleep diagnostic products ... transaction were not disclosed. Completion of the sale is subject to ... will form the world,s largest company to focus entirely on sleep ...
... , Unanimous Decision on Med Mal, Negligence, and TAPA ... arbitration panel found in favor of the estate of Mrs. Voncil Sherrod, ... High Pointe Health and Rehabilitation, a Mariner Health Care nursing home in ... Connor and Henry Giessel of the firm Marks, Balette & Giessel, P.C. ...
... Treat Diseases (the "Company") (HTDS.PK) announced today that it has ... longer selling shares of its common stock to accredited investors. ... Exchange Commission shortly, disclosing that the company has raised $990,000 ... to any such offering is $1 million per year. , ...
Cached Medicine News:Health News:New grants expand US infectious disease modeling effort 2Health News:New grants expand US infectious disease modeling effort 3Health News:Jewish Stem Cell Donor Urgently Sought for Young NJ Man Battling Aggressive Non-Hodgkin Lymphoma 2Health News:Jewish Stem Cell Donor Urgently Sought for Young NJ Man Battling Aggressive Non-Hodgkin Lymphoma 3Health News:Rewards Are Key to Cooperation 2Health News:Embla(R) Systems Announces the Acquisition of the Sandman(R) Sleep Diagnostic Business from Covidien(R) - Creating the World's Largest Sleep Diagnostic Company 2Health News:Arbitration Panel Finds in Favor of Tennessee Victim of Mariner Nursing Home Negligence 2Health News:Hard To Treat Diseases (HTDS) to Retire Regulation D 504 Offering 2Health News:Hard To Treat Diseases (HTDS) to Retire Regulation D 504 Offering 3
(Date:9/3/2015)... , Sept. 3, 2015  Cipla, a global pharmaceutical ... everyday needs of all patients, today announced that its ... to acquire two US-based companies, InvaGen Pharmaceuticals Inc., and ... closing conditions, is valued at $550 million and will ... these transactions is over $200 million for the year ...
(Date:9/3/2015)... Report Details What can be ... going to grow at the fastest rates? Visiongain,s brand ... data, trends, opportunities and prospects there. Our ... the most lucrative areas in the industry and the ... forecasted sales at overall world market and regional level. ...
(Date:9/3/2015)... Sept. 3, 2015 With a population of ... country and therefore also its single largest potential market ... China has led all major world economies in the ... expenditures, and government health expenditures. As an in vitro ... markets of the United States, western European countries, and ...
Breaking Medicine Technology:Cipla to acquire 100% of generic businesses in US for $550M 2Cipla to acquire 100% of generic businesses in US for $550M 3Cipla to acquire 100% of generic businesses in US for $550M 4Cipla to acquire 100% of generic businesses in US for $550M 5Ophthalmic Devices Market Forecast 2015-2025: Future Prospects for Leading Companies in Vision Care, Surgical, Diagnostic & Monitoring Devices 2Ophthalmic Devices Market Forecast 2015-2025: Future Prospects for Leading Companies in Vision Care, Surgical, Diagnostic & Monitoring Devices 3Ophthalmic Devices Market Forecast 2015-2025: Future Prospects for Leading Companies in Vision Care, Surgical, Diagnostic & Monitoring Devices 4IVD in China 2IVD in China 3IVD in China 4IVD in China 5IVD in China 6IVD in China 7IVD in China 8IVD in China 9IVD in China 10IVD in China 11IVD in China 12IVD in China 13
... to use: when presented in convenient, ... easy to pick up directly from ... the 96 tips are loaded without ... with a security sticker. Fully autoclavable, ...
This pipette tip facilitates the loading of samples onto polyacrylamide gels for DNA sequencing. The Geloader Tip has a 15 mm capillary with a defined diameter of less than 0.3 mm. The flexibility of...
1200 L, Racked, 96 tips/rack, 10 racks/box Recommended for 1200 L SofTouch electronic pipettes....
Designed to fit the Brinkmann Tranferpette and Treff Multi-Channel 300 L Pipettors, this tip provides extra space for repeat pipetting....
Medicine Products: